Analysis of different evaluation indexes for prostate stereotactic body radiation therapy plans: conformity index, homogeneity index and gradient index

T Cao, Z Dai, Z Ding, W Li… - Precision Radiation …, 2019 - Wiley Online Library
Objective This study analyzed different definitions of the conformity index (CI), homogeneity
index (HI), and gradient index (GI) used in evaluation of prostate cancer stereotactic body …

[HTML][HTML] Analytical dosimetric study of intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) for prostate cancer

F Samir, TM Meaz, FAE Hussiny, AA Ahmed… - Journal of Cancer …, 2023 - Springer
Purpose The study aimed to compare the dosimetric results and treatment delivery efficiency
among four techniques to explore the preferred technique in prostate treatment. Materials …

Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy

C Onal, S Sonmez, G Erbay, OC Guler… - The British journal of …, 2014 - academic.oup.com
Objective: This study compared the dosimetry of volumetric-arc therapy (VMAT) and intensity-
modulated radiotherapy (IMRT) with a dynamic multileaf collimator using the Monte Carlo …

[PDF][PDF] Comparison of hybrid volumetric modulated arc therapy (VMAT) technique and double arc VMAT technique in the treatment of prostate cancer

C Amaloo, DP Nazareth, LK Kumaraswamy - Radiology and oncology, 2015 - sciendo.com
Background. Volumetric modulated arc therapy (VMAT) has quickly become accepted as
standard of care for the treatment of prostate cancer based on studies showing it is able to …

[HTML][HTML] Optimal image guided radiation therapy strategy for organs at risk sparing in radiotherapy of the prostate including pelvic lymph nodes

A Van Nunen, PPG van der Toorn… - Radiotherapy and …, 2018 - Elsevier
Background and purpose Purpose of this study was to quantify the OAR dose for different
position correction strategies, and to determine which strategy is most optimal for treating …

[HTML][HTML] Dosimetric analysis of three-dimensional conformal radiotherapy, intensity-modulated radiotherapy-step and shoot, helical tomotherapy, and volumetric …

F Gozal, SA Gondhowiardjo, H Kodrat… - Journal of Cancer …, 2021 - journals.lww.com
Materials and Methods: Experimental study with intervention on ten prostate cancer patients'
computed tomography planning data. 78 Gy dose in 39 fractions was given for planning …

[HTML][HTML] Volumetric modulated arc therapy versus intensity modulated radiation therapy in the treatment of prostate Cancer: a systematic literature review

I Lalya, N Zaghba, K Andaloussi-Saghir… - … Journal of Radiology …, 2016 - cancerresgroup.us
Aim: provide evidence concerning advantages of volumetric modulated arc therapy over
intensity modulated radiation therapy. Background: external beam radiation therapy is a …

[PDF][PDF] Which Dosimetric Technique is Better; 3D-CRT, IMRT or VMAT in High Risk Prostate Cancer Treated by Hypofractionated radiotherapy with Elective Nodal …

MW Hegazy, E Mostafa, N Nawar - cancer - secioj.journals.ekb.eg
Background: Prostate cancer is not common in Arab countries. In this study, our aim is to
investigate which dosimetric technique has better target coverage and organs sparing; 3D …

[PDF][PDF] Assessment the performances of four commercial treatment planning systems for simultaneous integrated boost IMRT of prostate cancer

EM Attalla, M Hassan, MM Ahmed… - Iranian Journal of …, 2023 - academia.edu
Presently prostate cancer is the most common cancer among males in the USA. Based
totally on the degree, the treatment options available to prostate cancer patients consist of …

[PDF][PDF] A Dosimetric Comparison of 7 Field IMRT, 9 Field IMRT, VMAT and 3-D Conformal Radiotherapy for the Treatment of Localized Intermediate Risk Prostate …

K Ekici, M Kuloglu, AO Ata, O Atahan… - … : International Journal of …, 2022 - uhod.org
The objective of this study was to invastigate the potential role of various radiotherapy
planning methods for localised intermediate risk prostate cancer. We compare Linac-based …